Dabrafenib Impurity 1 | CAS 2017554-98-0 - Request Quote
Dabrafenib Impurity 1
| SZ CAT No: | SZ-D120003 |
| CAS No | 2017554-98-0 |
| Mol.F. | C23H22F2N6O2S2 |
| Mol.Wt. | 516.6 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabrafenib Impurity 1 is chemically 2-Amino-N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-6-fluorobenzenesulfonamide. Dabrafenib Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Dabrafenib Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabrafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2017554-98-0
Purchase 2017554-98-0
Order 2017554-98-0
Enquire 2017554-98-0
price of 2017554-98-0
2017554-98-0 Supplier
2017554-98-0 Manufacturer
2017554-98-0 Exporter
buy high quality Dabrafenib Impurity 1
Purchase Dabrafenib Impurity 1
Dabrafenib Impurity 1 suppliers
Dabrafenib Impurity 1 manufacturers
Dabrafenib Impurity 1 price
Order Dabrafenib Impurity 1
Enquire Dabrafenib Impurity 1
Dabrafenib Impurity 1 cost
Dabrafenib Impurity 1 Supplier
Dabrafenib Impurity 1 Distributor
Dabrafenib Impurity 1 for Method Validation
Dabrafenib Reference Standard
Dabrafenib Impurity 1 for ANDA Filing
Dabrafenib Impurity 1 for Forced Degradation Studies
Dabrafenib Impurity 1 Identification Standards
Dabrafenib Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


